Stock data
aTyr Pharma, Inc. (ATYR)
aTyr Pharma, Inc. (ATYR) reported revenue of US$0.19M and net income of -US$74.12M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.19M | — | -US$77.63M | -US$74.12M | — |
| 2024 | US$0.23M | — | -US$67.91M | -US$64.02M | — |
| 2023 | US$0.35M | — | -US$54.92M | -US$50.39M | — |
| 2022 | US$10.39M | — | -US$46.40M | -US$45.34M | — |
| 2021 | US$0.00M | — | -US$34.02M | -US$33.77M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$10.31M | — |
| 2026-03-31 | — | -US$10.79M | — |
| 2025-12-31 | US$0.00M | -US$13.96M | — |
| 2025-09-30 | US$0.19M | -US$25.74M | — |
| 2025-06-30 | US$0.00M | -US$19.53M | — |
| 2025-03-31 | US$0.00M | -US$14.88M | — |
| 2024-12-31 | US$0.00M | -US$14.97M | — |
| 2024-09-30 | US$0.00M | -US$17.26M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.